7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7D-1D Comparison)
SQLNS:7Dv1D
Assessing the Performance of 7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7Dv1D Comparison)
1 other identifier
interventional
505
1 country
1
Brief Summary
This cluster-randomized crossover trial evaluates whether the packaging format of small-quantity lipid-based nutrient supplements (SQ-LNS) affects caregiver adherence and acceptability when SQ-LNS are delivered through routine growth monitoring services in Northern Ghana. SQ-LNS are a proven intervention for reducing child malnutrition, but packaging format may affect how caregivers store, dispense, and use the product, and it also drives cost and distribution logistics. Up to sixteen health facilities participating in growth monitoring services each deliver both formats: a 1-day sachet (20 g daily) and a 7-day resealable pouch (140 g weekly), with the order of delivery randomized at facility level. Each format is delivered for one month before crossover, and caregivers receive a 28-day supply totaling 560 g in each period regardless of format. The primary outcome is adherence, measured by weighing SQ-LNS returned unconsumed and expressed as the percentage of dispensed product consumed. The trial tests whether adherence with the 7-day pouch is non-inferior to adherence with 1-day sachets, using a margin of 5.0 percentage points. Secondary outcomes include caregiver acceptability and preference, observed dispensing accuracy and package opening, and qualitative assessment of implementation facilitators and barriers. This implementation research study uses a convergent mixed-methods design, integrating quantitative adherence and acceptability data with in-depth interviews and structured observations to inform real-world program implementation. Findings will guide policy and program decisions for integrating SQ-LNS into child health platforms in Ghana and other low-resource settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedStudy Start
First participant enrolled
September 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
October 1, 2026
September 1, 2026
4 months
August 5, 2025
September 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence to SQ-LNS, measured as the percentage of dispensed product consumed
Weight-based adherence, calculated as 100 × (grams of SQ-LNS dispensed - grams of SQ-LNS returned unconsumed) / grams of SQ-LNS dispensed, with returned product weighed net of packaging tare. Participants in both arms receive a 28-day supply totaling 560 g per period (28 × 20 g sachets in the 1-day sachet arm; 4 × 140 g resealable pouches in the 7-day pouch arm). Returned product is weighed at the first contact point reached, following a fixed sequence: the next scheduled growth monitoring clinic visit, then a community outreach growth monitoring event, then a home visit. The 7-day resealable pouch is assessed for non-inferiority to the 1-day sachet using a non-inferiority margin of 5.0 percentage points.
Measured twice per participant: End of each one-month packaging period (Period 1 and Period 2)
Secondary Outcomes (4)
Caregiver acceptability/usability
Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase
Caregiver experience with SQ-LNS
At the end of each 1-month crossover period (following each intervention phase)
Dispensing accuracy, measured as the percentage of caregivers dispensing a single day's dose within ±2 g of the 20 g target
at the end of the first 1-month phase and at the end of the second 1-month phase
Percentage of caregivers opening the package without a tool or assistance
at the end of the first 1-month phase and at the end of the second 1-month phase
Study Arms (2)
Arm 1 (1-day sachet first)
ACTIVE COMPARATORCaregivers at facilities randomized to this sequence receive SQ-LNS in 1-day 20 g sachets (28 sachets, 560 g) during the first month, then 7-day 140 g resealable pouches (4 pouches, 560 g) during the second month.
Arm 2 (7-day pouch first)
EXPERIMENTALCaregivers at facilities randomized to this sequence receive SQ-LNS in 7-day 140 g resealable pouches (4 pouches, 560 g) during the first month, then 1-day 20 g sachets (28 sachets, 560 g) during the second month.
Interventions
Small-quantity lipid-based nutrient supplements are delivered through routine growth monitoring and promotion services in two packaging formats: 1-day 20 g sachets (20DS) and 7-day 140 g resealable pouches (7DRP). Every caregiver receives both formats, one per month, in the order determined by their facility's randomized sequence. In each period the caregiver receives a 28-day supply totaling 560 g.
Eligibility Criteria
You may qualify if:
- The caregiver is 18 years or older and is the primary caregiver of the child
- The child is 6-24 months of age at the time of enrollment
- The child is eligible to receive routine growth monitoring and promotion services at the participating clinic
- The caregiver provides written informed consent to participate
You may not qualify if:
- The child has severe acute malnutrition (SAM) or medical complications requiring medication or inpatient care
- The child has a known allergy to peanuts, milk, or other components of the supplement, or has a medical condition that prevents consumption of complementary foods
- The caregiver or child is concurrently enrolled in another nutrition intervention study or clinical trial
- The family plans to relocate outside the study area during the two-month follow-up
- The caregiver is unwilling to provide informed consent or to follow the study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston University Charles River Campuslead
- Edesiacollaborator
- University of Ghanacollaborator
Study Sites (1)
Ghana Health Service facilities, Kumbungu and Tolon Districts
Kumbungu, Northern Region, Ghana
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsey Locks, ScD
Boston University Charles River Campus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2025
First Posted
August 19, 2025
Study Start
September 28, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
October 1, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share